Green growth at Danish biotech firm Novozymes

Denmark's Novozymes saw improvements in the sale of enzymes for production of bioethanol during the first quarter 2017.

Photo: Novozymes

Danish biotech company Novozymes has struggled for years to get its bioenergy business up and running, but the division always lagged behind. However, the company remained optimistic and announced back in January that brighter days were right around the corner.

Where this corner was, and how far Novozymes had to venture to get there, is hard to say. Yet one thing is certain: Novozymes has made significant progress.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from EnergyWatch

Equinor says renewables still maturing

Like most other oil firms, Norway's Equinor aims to become greener. But the maturation of its renewable energy portfolio impacts the company in Q2, which sees a deficit of USD 31 in renewables.

The 'new' Seadrill estimated to be worth USD 1.2bn

SEB evaluates that the recently restructured Seadrill will have a fair equity value of about USD 1.2bn. Since the news of the restructuring broke over the weekend, the Seadrill stock price has only plummeted.

Further reading

Related articles

Trial banner

Latest News

See all jobs